Home » Topics » Regulatory

Regulatory
RSS

Zohydro ER approved by the FDA for pain

Oct. 28, 2013

FDA approves GE Healthcare's brain imaging drug for Alzheimer's disease and dementia

Oct. 28, 2013

European approval of Gentium's Defitelio for severe veno-occlusive disease

Oct. 23, 2013

FDA approves Cimzia for ankylosing spondylitis, issues complete response letter for axSpA

Oct. 21, 2013

FDA approves Opsumit for PAH

Oct. 21, 2013

FDA approves Novoeight for use in adults and children with hemophilia A

Oct. 17, 2013

Duavee approved for vasomotor symptoms and preventing postmenopausal osteoporosis

Oct. 4, 2013

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

FDA grants accelerated approval of new indication for Perjeta

Oct. 2, 2013

FDA approves vortioxetine for major depressive disorder

Oct. 1, 2013